MEDP MEDPACE HOLDINGS INC

2026Q1 · CUSIP 58506Q109 · Sector: Healthcare & Biotech

Danger · Dual-confirm: breadth + price

Holders

724

Δ holders QoQ

-54

Breadth percentile

Top 98%

Whale holders

253

Δ whales

-2

Inst. holding value

$11.4B

New positions

Closed positions

141

Price momentum (1Q)

-1.8%

Put / Call

5/4

Breadth history (34 quarters)

Past Lit Events & Aftermath 16 lit events

Period	Percentile	Next-1Q return	Next-2Q return
2025Q4	Top 3%	-1.8%	—
2025Q3	Top 2%	-23.8%	-28.0%
2024Q2	Top 10%	-13.5%	-11.1%
2024Q1	Top 4%	-0.3%	-21.0%
2023Q4	Top 8%	+0.4%	+0.1%
2023Q3	Top 5%	+36.5%	+41.1%
2023Q2	Top 3%	+10.4%	+54.3%
2022Q4	Top 4%	+1.5%	+21.2%
2022Q3	Top 5%	-8.3%	-6.4%
2021Q4	Top 10%	-10.4%	+19.0%
2021Q3	Top 15%	-34.8%	-41.5%
2020Q3	Top 7%	+35.0%	+35.9%
2020Q1	Top 4%	+47.7%	+35.3%
2019Q3	Top 2%	+40.3%	+26.5%
2018Q3	Top 1%	+24.8%	+5.1%
2018Q2	Top 6%	-4.2%	+21.0%

Show all 16 events

Options Sentiment

Put holders

QoQ: +1

Call holders

QoQ: 0

See methodology →

Fundamentals

PE (TTM)

33.8

EPS (TTM)

$15.89

EPS YoY

+21.3%

Revenue (TTM)

$2.7B

Revenue YoY

+24.2%

Net margin

17.2%

ROE

77.0%

Debt ratio

71.9%

FCF (TTM)

$711M

Dividend (TTM)

No dividend

Quarterly Revenue & EPS (4Y)

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)

Get the next update

2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.